MedPath

Translation and validation of a Questionare(PedsQL 3.0 Cancer module) into Indian languages (Marathi & Hindi) to study Quality of Life of pediatric solid tumor patients from a tertiary care cancer centre

Not Applicable
Conditions
Health Condition 1: null- before surgery and after surgery patient followup
Registration Number
CTRI/2016/12/007551
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Pediatric solid tumor patients of either gender whose

age is between 2-18 years who have been diagnosed

and have consented to undergo treatment at Tata

Memorial Centre after adequate staging workup

Exclusion Criteria

Patients who do not meet the above criteria.

Patients unwilling to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Symptoms Scales <br/ ><br>i) Pain <br/ ><br>ii) Nausea <br/ ><br>iii) Anxiety <br/ ><br>iv) Worry <br/ ><br>2 Functional scales <br/ ><br>i) Cognitive assessment <br/ ><br>ii) Perception of self body image <br/ ><br>iii) Communication <br/ ><br> <br/ ><br>Timepoint: There are no significant risks to the participants in this study. Patient might have tospend about 20-25 minutes for completing the Questionnaire <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Though newer therapeutic options have resulted in improved health status of patients, the prolonged and frequent hospitalizations during this sensitive period of life could negatively impact child development. Also, in view of good survival, tools to assess clinical outcomes of different treatment modalities need to be developed. Therefore, there is focus on the developmentof instruments to assess health-related quality of life (HRQOL) outcomes.Timepoint: Assessing important side effects / complications following treatment for the medical professionals <br/ ><br>and step towards improving quality of life and <br/ ><br>minimizing the side effects. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath